上海医药集团股份有限公司（股票代码：02607）于2026年7月2日发布6月证券变动月报表，披露2026年6月1日至6月30日期间的股本结构及相关变更情况。
报告显示，公司H股（普通股）于期初和期末均为919,072,704股；A股（普通股）于期初和期末也均为2,789,289,105股，两类股份在报告期内均未发生增发、回购或注销，库藏股数量亦无变动。至报告期末，公司法定注册股本总额为3,708,361,809股，仍与上月持平，股本结构保持稳定。公司同时确认，不存在股份期权、股权激励计划或可换股票据等相关变化。
上述月报由公司联席公司秘书钟涛签署。公司确认已严格遵守香港联合交易所有限公司《上市规则》及其他法律法规的相关要求。根据公告，本次报告期内，公司股本维持不变，未发生任何新增发行、购回或注销股票的活动。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.